| The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma E Tian, F Zhan, R Walker, E Rasmussen, Y Ma, B Barlogie, ... New England Journal of Medicine 349 (26), 2483-2494, 2003 | 1824 | 2003 |
| The molecular classification of multiple myeloma F Zhan, Y Huang, S Colla, JP Stewart, I Hanamura, S Gupta, J Epstein, ... Blood 108 (6), 2020-2028, 2006 | 1260 | 2006 |
| International Myeloma Working Group molecular classification of multiple myeloma: spotlight review R Fonseca, PL Bergsagel, J Drach, J Shaughnessy, N Gutierrez, ... Leukemia 23 (12), 2210-2221, 2009 | 1182 | 2009 |
| Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma CM Annunziata, RE Davis, Y Demchenko, W Bellamy, A Gabrea, F Zhan, ... Cancer cell 12 (2), 115-130, 2007 | 1138 | 2007 |
| A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1 JD Shaughnessy Jr, F Zhan, BE Burington, Y Huang, S Colla, I Hanamura, ... Blood 109 (6), 2276-2284, 2007 | 1084 | 2007 |
| Genetics and cytogenetics of multiple myeloma: a workshop report R Fonseca, B Barlogie, R Bataille, C Bastard, PL Bergsagel, M Chesi, ... Cancer research 64 (4), 1546-1558, 2004 | 935 | 2004 |
| Absence epilepsy in tottering mutant mice is associated with calcium channel defects CF Fletcher, CM Lutz, TN O'Sullivan, JD Shaughnessy, R Hawkes, ... Cell 87 (4), 607-617, 1996 | 904 | 1996 |
| Thalidomide and hematopoietic-cell transplantation for multiple myeloma B Barlogie, G Tricot, E Anaissie, J Shaughnessy, E Rasmussen, ... New England Journal of Medicine 354 (10), 1021-1030, 2006 | 892 | 2006 |
| Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma PL Bergsagel, WM Kuehl, F Zhan, J Sawyer, B Barlogie, ... Blood 106 (1), 296-303, 2005 | 875 | 2005 |
| The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models Nature biotechnology 28 (8), 827-838, 2010 | 849 | 2010 |
| Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells F Zhan, J Hardin, B Kordsmeier, K Bumm, M Zheng, E Tian, R Sanderson, ... Blood, The Journal of the American Society of Hematology 99 (5), 1745-1757, 2002 | 814 | 2002 |
| CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma ED Hsi, R Steinle, B Balasa, S Szmania, A Draksharapu, BP Shum, ... Clinical Cancer Research 14 (9), 2775-2784, 2008 | 645 | 2008 |
| Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia T Nakamura, DA Largaespada, MP Lee, LA Johnson, K Ohyashiki, ... Nature genetics 12 (2), 154-158, 1996 | 597 | 1996 |
| Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related … I Hanamura, JP Stewart, Y Huang, F Zhan, M Santra, JR Sawyer, ... Blood 108 (5), 1724-1732, 2006 | 584 | 2006 |
| F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma TB Bartel, J Haessler, TLY Brown, JD Shaughnessy Jr, F van Rhee, ... Blood, The Journal of the American Society of Hematology 114 (10), 2068-2076, 2009 | 555 | 2009 |
| Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo S Yaccoby, W Ling, F Zhan, R Walker, B Barlogie, JD Shaughnessy Jr Blood 109 (5), 2106-2111, 2007 | 536 | 2007 |
| High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients DR Carrasco, G Tonon, Y Huang, Y Zhang, R Sinha, B Feng, JP Stewart, ... Cancer cell 9 (4), 313-325, 2006 | 524 | 2006 |
| The role of Dickkopf-1 in bone development, homeostasis, and disease JJ Pinzone, BM Hall, NK Thudi, M Vonau, YW Qiang, TJ Rosol, ... Blood, The Journal of the American Society of Hematology 113 (3), 517-525, 2009 | 498 | 2009 |
| Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications R Walker, B Barlogie, J Haessler, G Tricot, E Anaissie, ... Journal of clinical Oncology 25 (9), 1121-1128, 2007 | 491 | 2007 |
| Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib G Mulligan, C Mitsiades, B Bryant, F Zhan, WJ Chng, S Roels, E Koenig, ... Blood 109 (8), 3177-3188, 2007 | 461 | 2007 |
